Novo Nordisk A/S ADR buy Kepler Capital Markets
Start price
13.03.25
/
50%
€71.00
Target price
13.03.26
-
Performance (%)
-52.68%
End price
14.03.26
€33.60
Summary
This prediction ended on 14.03.26 with a price of €33.60. Massive losses of -52.68% were the result for the BUY prediction by Kepler_Capital_Marke. Dividends of €1.10 are taken into consideration when calculating the performance. Kepler_Capital_Marke has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -5.255% | -5.255% | -56.781% |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% |
Comments by Kepler_Capital_Marke for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von Kepler_Capital_Marke gewählte maximale Laufzeit wurde überschritten